Immediate Impact
61 standout
Citing Papers
Ultralight crystalline hybrid composite material for highly efficient sequestration of radioiodine
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Josef J. Fox being referenced
Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE
2022
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Josef J. Fox | 570 | 821 | 281 | 50 | 1.2k | |
| Chang Woon Choi | 691 | 403 | 261 | 73 | 1.3k | |
| Ilhan Lim | 575 | 467 | 184 | 73 | 1.0k | |
| Yukiko Arisaka | 506 | 501 | 313 | 30 | 990 | |
| Emre Demirci | 668 | 786 | 346 | 39 | 1.2k | |
| Filippo Lodi | 822 | 751 | 243 | 44 | 1.4k | |
| Riccardo Laudicella | 670 | 524 | 284 | 96 | 1.2k | |
| Michael J. Katin | 253 | 805 | 225 | 44 | 1.1k | |
| Edward Hsiao | 669 | 792 | 345 | 51 | 1.4k | |
| Gustavo Mercier | 701 | 450 | 235 | 42 | 1.3k | |
| Barbara Röper | 629 | 525 | 152 | 33 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...